$4000 | Single User
$6000 | Site License
$8000 | Enterprise License

Dermatology Drugs Market Global Report 2017
Including: Antibacterial, Anti-Fungal, Anti-Viral
Covering: Galderma (Nestle Skin Health), Johnson & Johnson, AbbVie, GlaxosmithKline, and Pfizer
[Report Updated: 17-07-2017]

Published by The Business Research Company: 17 Jul 2017 | 109253 | In Stock
Related Topics: Dermatology , Pfizer

Introduction

The market has witnessed multiple strategic initiatives in the recent years. Top companies in the dermatology drugs market strategically acquired start-ups and mid-sized companies to broaden products and services.

The Dermatology Drugs Market Global Report provides strategists, marketers and senior management with the critical information they need to assess the global dermatology drugs sector.


Reasons to Purchase

• Outperform competitors using accurate up to date demand-side dynamics information.

• Identify growth segments for investment.

• Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.

• Create regional and country strategies on the basis of local data and analysis.

• Stay abreast of the latest customer and market research findings

• Benchmark performance against key competitors.

• Develop strategies based on likely future developments.

• Utilize the relationships between key data sets for superior strategizing.

• Suitable for supporting your internal and external presentations with reliable high quality data and analysis

• Gain a global perspective on the development of the market.

• Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:

Where is the largest and fastest growing market for the dermatology drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The dermatology drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider pharmaceutical drugs market, and compares it with other markets.

• The market characteristics section of the report defines and explains the market.

• The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.

• Market segmentations break down market into sub markets.

• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.

• Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.

• The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.

• The dermatology drugs market section of the report gives context. It compares the dermatology drugs market with other segments of the pharmaceutical drugs market by size and growth, historic and forecast. It analyses Expenditure Per Capita, The Dermatology Drugs Indicators Comparison.

• The industry metrics section looks at critical drivers including patient numbers (epidemiology) hospital beds and specialist physicians while the macro-economic section looks at the market in relation to the overall economy.

Scope

Markets Covered: Antibacterial, Anti-Fungal, Anti-Viral

Companies Mentioned: Galderma (Nestle Skin Health), Johnson & Johnson, AbbVie, GlaxosmithKline, and Pfizer

Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia.

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP, Expenditure Per Capita, The Dermatology Drugs Indicators Comparison.


Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents
for Dermatology Drugs Market Global Report 2017 Including: Antibacterial, Anti-Fungal, Anti-Viral Covering: Galderma (Nestle Skin Health), Johnson & Johnson, AbbVie, GlaxosmithKline, and Pfizer [Report Updated: 17-07-2017]

  • 1. Dermatology Drugs Market Characteristics;

    2. Dermatology Drugs Market Size And Growth;

    2.1. Historic Market Growth; 2.1.1. Drivers Of The Market; 2.1.2. Restraints On The Market; 2.2. Forecast Market Growth; 2.2.1. Drivers Of The Market; 2.2.2. Restraints On The Market;

    3. Pestle Analysis;

    3.1. Political; 3.2. Economic; 3.3. Social; 3.4. Technological; 3.5. Legal; 3.6. Environmental;

    4. Dermatology Drugs Market Customer Information;

    5. Dermatology Drugs Market Segmentation;

    5.1. Global Dermatology Drugs Market, 2016, By Segment; Antibacterial; Anti-Fungal; Anti-Viral; 5.2. Global Dermatology Drugs Market, 2012 - 2020, Historic And Forecast, By Segment; 5.3 Global Dermatology Drugs Market Trends And Strategies;

    6. Dermatology Drugs Market Regional And Country Analysis;

    6.1. Global Dermatology Drugs Market, 2016, By Region; 6.2. Global Dermatology Drugs Market, 2012 - 2020, Historic And Forecast, By Region; 6.3. Dermatology Drugs Market, 2016, By Country; 6.4. Dermatology Drugs Market, 2012 - 2020, Historic And Forecast, By Country; 6.5. Global Pharmaceutical Market Segments, 2016, By Region; 6.6. Global Pharmaceutical Drugs Market Segments, 2016, By Region; 6.7. Global Pharmaceutical Market Segments, 2016, By Country; 6.8. Global Pharmaceutical Drugs Market Segments, 2016, By Country;

    7. Global Dermatology Drugs Market Comparison With Macro Economic Factors;

    7.1. Dermatology Drugs Market Size, Percentage Of GDP, Global; 7.2. Per Capita Average Dermatology Drugs Expenditure, Global;

    8. Dermatology Drugs Market Comparison With Macro Economic Factors Across Countries;

    8.1. Dermatology Drugs Market Size, Percentage Of GDP, By Country; 8.2. Per Capita Average Dermatology Drugs Expenditure, By Country;

    9. Dermatology Drugs Market Comparison With Industry Metrics;

    9.1. Global Number Of Pharmacists, 2016, By Country; 9.2. Global Dermatology Drugs Market Revenue Versus Number Of Pharmacists, 2016, By Country; 9.3. Global Number Of Pharma Enterprises, 2016, By Country; 9.4. Global Dermatology Drugs Market Revenue Versus Number Of Pharma Enterprises, 2016, By Country; 9.5. Global Average Spending On R&D/Product Development, 2016, By Country; 9.6. Global Dermatology Drugs Market Revenue Versus Average Spending On R&D/Product Development, 2016, By Country; 9.7. Global Generic & Branded Sales Proportion By Country (Value), 2016, By Country; 9.8. Global Dermatology Drugs Market Revenue Versus Generic & Branded Sales Proportion By Country (Value), 2016, By Country; 9.9. Prevalent Cases Of Dermatitis, 2014, By Country;

    10. Asia-Pacific Dermatology Drugs Market;

    10.1.1. Asia-Pacific Dermatology Drugs Market Overview; 10.1.2. Asia-Pacific Dermatology Drugs Historic Market, 2012 - 2016; 10.1.3. Asia-Pacific Dermatology Drugs Forecast Market, 2016 - 2020; 10.1.4. Asia-Pacific Dermatology Drugs Market, 2016, By Segment; Antibacterial; Anti-Fungal; Anti-Viral; 10.2. Asia-Pacific Dermatology Drugs Market: Country Analysis; 10.3. China Dermatology Drugs Market; 10.3.1. China Dermatology Drugs Market Overview; 10.3.2. China Dermatology Drugs Historic Market, 2012 - 2016; 10.3.3. China Dermatology Drugs Forecast Market, 2016 - 2020; 10.3.4. China Dermatology Drugs Market, 2016, By Segment; Antibacterial; Anti-Fungal; Anti-Viral; 10.3.5. China Dermatology Drugs Percentage Of GDP, 2012 - 2020; 10.3.6. China Per Capita Average Dermatology Drugs Expenditure, 2012 - 2020; 10.4. India Dermatology Drugs Market; 10.4.1. India Dermatology Drugs Market Overview; 10.4.2. India Dermatology Drugs Historic Market, 2012 - 2016; 10.4.3. India Dermatology Drugs Forecast Market, 2016 - 2020; 10.4.4. India Dermatology Drugs Market, 2016, By Segment; Antibacterial; Anti-Fungal; Anti-Viral; 10.4.5. India Dermatology Drugs Percentage Of GDP, 2012 - 2020; 10.4.6. India Per Capita Average Dermatology Drugs Expenditure, 2012 - 2020; 10.5. Japan Dermatology Drugs Market; 10.5.1. Japan Dermatology Drugs Market Overview; 10.5.2. Japan Dermatology Drugs Historic Market, 2012 - 2016; 10.5.3. Japan Dermatology Drugs Forecast Market, 2016 - 2020; 10.5.4. Japan Dermatology Drugs Market, 2016, By Segment; Antibacterial; Anti-Fungal; Anti-Viral; 10.5.5. Japan Dermatology Drugs Percentage Of GDP, 2012 - 2020; 10.5.6. Japan Per Capita Average Dermatology Drugs Expenditure, 2012 - 2020; 10.6. Australia Dermatology Drugs Market; 10.6.1. Australia Dermatology Drugs Historic Market, 2012 - 2016; 10.6.2. Australia Dermatology Drugs Forecast Market, 2016 - 2020; 10.6.3. Australia Dermatology Drugs Market, 2016, By Segment; Antibacterial; Anti-Fungal; Anti-Viral; 10.6.4. Australia Dermatology Drugs Percentage Of GDP, 2012 - 2020; 10.6.5. Australia Per Capita Average Dermatology Drugs Expenditure, 2012 - 2020;

    11. Western Europe Dermatology Drugs Market;

    11.1.1. Western Europe Dermatology Drugs Market Overview; 11.1.2. Western Europe Dermatology Drugs Historic Market, 2012 - 2016; 11.1.3. Western Europe Dermatology Drugs Forecast Market, 2016 - 2020; 11.1.4. Western Europe Dermatology Drugs Market, 2016, By Segment; Antibacterial; Anti-Fungal; Anti-Viral; 11.2. Western Europe Dermatology Drugs Market: Country Analysis; 11.3. UK Dermatology Drugs Market; 11.3.1. UK Dermatology Drugs Market Overview; 11.3.2. UK Dermatology Drugs Historic Market, 2012 - 2016; 11.3.3. UK Dermatology Drugs Forecast Market, 2016 - 2020; 11.3.4. UK Dermatology Drugs Market, 2016, By Segment; Antibacterial; Anti-Fungal; Anti-Viral; 11.3.5. UK Dermatology Drugs Percentage Of GDP, 2012 - 2020; 11.3.6. UK Per Capita Average Dermatology Drugs Expenditure, 2012 - 2020; 11.4. Germany Dermatology Drugs Market; 11.4.1. Germany Dermatology Drugs Historic Market, 2012 - 2016; 11.4.2. Germany Dermatology Drugs Forecast Market, 2016 - 2020; 11.4.3. Germany Dermatology Drugs Market, 2016, By Segment; Antibacterial; Anti-Fungal; Anti-Viral; 11.4.4 Germany Dermatology Drugs Percentage Of GDP, 2012 - 2020; 11.4.5 Germany Per Capita Average Dermatology Drugs Expenditure, 2012 - 2020; 11.5 France Dermatology Drugs Market; 11.5.1 France Dermatology Drugs Historic Market, 2012 - 2016; 11.5.2 France Dermatology Drugs Forecast Market, 2016 - 2020; 11.5.3 France Dermatology Drugs Market, 2016, By Segment; Antibacterial; Anti-Fungal; Anti-Viral; 11.5.4 France Dermatology Drugs Percentage Of GDP, 2012 - 2020; 11.5.5 France Per Capita Average Dermatology Drugs Expenditure, 2012 - 2020; 11.6. Italy Dermatology Drugs Market; 11.6.1. Italy Dermatology Drugs Historic Market, 2012 - 2016; 11.6.2. Italy Dermatology Drugs Forecast Market, 2016 - 2020; 11.6.3. Italy Dermatology Drugs Market, 2016, By Segment; Antibacterial; Anti-Fungal; Anti-Viral; 11.6.4. Italy Dermatology Drugs Percentage Of GDP, 2012 - 2020; 11.6.5. Italy Per Capita Average Dermatology Drugs Expenditure, 2012 - 2020; 11.7. Spain Dermatology Drugs Market; 11.7.1. Spain Dermatology Drugs Historic Market, 2012 - 2016; 11.7.2. Spain Dermatology Drugs Forecast Market, 2016 - 2020; 11.7.3. Spain Dermatology Drugs Market, 2016, By Segment; Antibacterial; Anti-Fungal; Anti-Viral; 11.7.4. Spain Dermatology Drugs Percentage Of GDP, 2012 - 2020; 11.7.5. Spain Per Capita Average Dermatology Drugs Expenditure, 2012 - 2020;

    12. Eastern Europe Dermatology Drugs Market;

    12.1.1. Eastern Europe Dermatology Drugs Market Overview; 12.1.2. Eastern Europe Dermatology Drugs Historic Market, 2012 - 2016; 12.1.3. Eastern Europe Dermatology Drugs Forecast Market, 2016 - 2020; 12.1.4 Eastern Europe Dermatology Drugs Market, 2016, By Segment; Antibacterial; Anti-Fungal; Anti-Viral; 12.2. Eastern Europe Dermatology Drugs Market: Country Analysis; 12.3. Russia Dermatology Drugs Market; 12.3.1. Russia Dermatology Drugs Historic Market, 2012 - 2016; 12.3.2. Russia Dermatology Drugs Forecast Market, 2016 - 2020; 12.3.3. Russia Dermatology Drugs Market, 2016, By Segment; Antibacterial; Anti-Fungal; Anti-Viral; 12.3.4. Russia Dermatology Drugs Percentage Of GDP, 2012 - 2020; 12.3.5. Russia Per Capita Average Dermatology Drugs Expenditure, 2012 - 2020;

    13. North America Dermatology Drugs Market;

    13.1.1. North America Dermatology Drugs Market Overview; 13.1.2. North America Dermatology Drugs Historic Market, 2012 - 2016; 13.1.3. North America Dermatology Drugs Forecast Market, 2016 - 2020; 13.1.4. North America Dermatology Drugs Market, 2016, By Segment; Antibacterial; Anti-Fungal; Anti-Viral; 13.2. North America Dermatology Drugs Market: Country Analysis; 13.3. USA Dermatology Drugs Market; 13.3.1. USA Dermatology Drugs Historic Market, 2012 - 2016; 13.3.1. USA Dermatology Drugs Historic Market, 2012 - 2016; 13.3.2. USA Dermatology Drugs Forecast Market, 2016 - 2020; 13.3.3 USA Dermatology Drugs Market, 2016, By Segment; Antibacterial; Anti-Fungal; Anti-Viral; 13.3.4. USA Dermatology Drugs Percentage Of GDP, 2012 - 2020; 13.3.5. USA Per Capita Average Dermatology Drugs Expenditure, 2012 - 2020;

    14. South America Dermatology Drugs Market;

    14.1.1. South America Dermatology Drugs Market Overview; 14.1.2. South America Dermatology Drugs Historic Market, 2012 - 2016; 14.1.3. South America Dermatology Drugs Forecast Market, 2016 - 2020; 14.1.4. South America Dermatology Drugs Market, 2016, By Segment; Antibacterial; Anti-Fungal; Anti-Viral; 14.2. South America Dermatology Drugs Market: Country Analysis; 14.3. Brazil Dermatology Drugs Market; 14.3.1. Brazil Dermatology Drugs Historic Market, 2012 - 2016; 14.3.2. Brazil Dermatology Drugs Forecast Market, 2016 - 2020; 14.3.3. Brazil Dermatology Drugs Market, 2016, By Segment; Antibacterial; Anti-Fungal; Anti-Viral; 14.3.4. Brazil Dermatology Drugs Percentage Of GDP, 2012 - 2020; 14.3.5. Brazil Per Capita Average Dermatology Drugs Expenditure, 2012 - 2020;

    15. Middle East Dermatology Drugs Market;

    15.1.1. Middle East Dermatology Drugs Market Overview; 15.1.2. Middle East Dermatology Drugs Historic Market, 2012 - 2016; 15.1.3. Middle East Dermatology Drugs Forecast Market, 2016 - 2020; 15.1.4. Middle East Dermatology Drugs Market, 2016, By Segment; Antibacterial; Anti-Fungal; Anti-Viral;

    16. Africa Dermatology Drugs Market;

    16.1.1. Africa Dermatology Drugs Market Overview; 16.1.2. Africa Dermatology Drugs Historic Market, 2012 - 2016; 16.1.3. Africa Dermatology Drugs Forecast Market, 2016 - 2020; 16.1.4. Africa Dermatology Drugs Market, 2016, By Segment; Antibacterial; Anti-Fungal; Anti-Viral;

    17. Dermatology Drugs Market Competitive Landscape;

    17.1. Company Profiles; 17.2. Galderma (Nestle Skin Health); 17.2.1. Overview; 17.2.2. Products And Services; 17.2.3. Strategy; 17.2.4. Financial Performance; 17.3. Johnson & Johnson; 17.3.1. Overview; 17.3.2. Products And Services; 17.3.3. Strategy; 17.3.4. Financial Performance; 17.4. Abbvie; 17.4.1. Overview; 17.4.2. Products And Services; 17.4.3. Strategy; 17.4.4. Financial Performance; 17.5. Glaxosmithkline; 17.5.1. Overview; 17.5.2. Products And Services; 17.5.3. Strategy; 17.5.4. Financial Performance; 17.6. Pfizer; 17.6.1. Overview; 17.6.2. Products And Services; 17.6.3. Strategy; 17.6.4. Financial Performance;

    18. Key Mergers And Acquisitions In The Dermatology Drugs Market;

    19. Market Background: Pharmaceutical Drugs Market;

    19.1.1. Pharmaceutical Drugs Market Characteristics; 19.1.2. Pharmaceutical Drugs Market Historic Growth; 19.1.2.1. Drivers Of The Market; 19.1.2.2. Restraints Of The Market; 19.1.3. Pharmaceutical Drugs Market Forecast Growth; 19.1.3.1. Drivers Of The Market; 19.1.3.2. Restraints Of The Market; 19.1.4. Pharmaceutical Drugs Trends And Strategies; 19.2. Pharmaceutical Drugs Market Regional And Country Analysis; 19.2.1. Global Pharmaceutical Drugs Market, 2016, By Region; 19.2.2. Global Pharmaceutical Drugs Market, 2012 - 2020, Historic And Forecast, By Region; 19.2.3. Pharmaceutical Drugs Market, 2016, By Country; 19.2.4. Pharmaceutical Drugs Market, 2012 - 2020, Historic And Forecast, By Country; 19.2.5. Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Segment; 19.2.6. Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Country And Segment; 19.3. Global Pharmaceutical Drugs Market Comparison With Macro Economic Factors; 19.3.2. Per Capita Average Pharmaceutical Drugs Expenditure, Global; 19.4. Pharmaceutical Drugs Market Comparison With Macro Economic Factors Across Countries; 19.4.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, By Country; 19.4.2. Per Capita Average Pharmaceutical Drugs Expenditure, By Country; 19.5. Key Mergers And Acquisitions In The Pharmaceutical Drugs Market;

    20. Pharmaceuticals Industry Financial Margins;

    21. Appendix;

    21.1. NAICS Definitions Of Industry Covered In This Report; 21.2. Abbreviations; 21.3. Currencies; 21.4. Research Inquiries; 21.5. The Business Research Company; 21.6. Copyright And Disclaimer

List Of Tables
in Dermatology Drugs Market Global Report 2017 Including: Antibacterial, Anti-Fungal, Anti-Viral Covering: Galderma (Nestle Skin Health), Johnson & Johnson, AbbVie, GlaxosmithKline, and Pfizer [Report Updated: 17-07-2017]

Table 1: Global Dermatology Drugs Historic Market Growth

Table 2: Global Dermatology Drugs Forecast Market Growth

Table 3: Dermatology Drugs Market Segmentation

Table 4: Global Dermatology Drugs Market, 2016, By Segment

Table 5: Global Dermatology Drugs Market, 2012 - 2020, Historic And Forecast, By Segment

Table 6: Global Dermatology Drugs Market, 2016, By Region

Table 7: Global Dermatology Drugs Market, 2012 - 2020, Historic And Forecast, By Region

Table 8: Dermatology Drugs Market, 2016, By Country

Table 9: Dermatology Drugs Market, 2012 - 2020, Historic And Forecast, By Country

Table 10: Global Pharmaceutical Market Segments, 2016, By Region

Table 11: Global Pharmaceutical Drugs Market Segments, 2016, By Region

Table 12: Global Pharmaceutical Market Segments, 2016, By Country

Table 13: Global Pharmaceutical Drugs Market Segments, 2016, By Country

Table 14: Dermatology Drugs Market Size, Percentage Of GDP, Global

Table 15: Per Capita Average Dermatology Drugs Expenditure, Global

Table 16: Dermatology Drugs Market Comparison With Macro Economic Factors Across Countries

Table 17: Dermatology Drugs Market Size, Percentage Of GDP, By Country

Table 18: Per Capita Average Dermatology Drugs Expenditure, By Country

Table 19: Global Number Of Pharmacists, 2016, By Country

Table 20: Global Dermatology Drugs Market Revenue Versus Number Of Pharmacists, 2016, By Country

Table 21: Global Number Of Pharma Enterprises, 2016, By Country

Table 22: Global Dermatology Drugs Market Revenue Versus Number Of Pharma Enterprises, 2016, By Country

Table 23: Global Average Spending On R&D/Product Development, 2016, By Country

Table 24: Global Dermatology Drugs Market Revenue Versus Average Spending On R&D/Product Development, 2016, By Country

Table 25: Global Generic & Branded Sales Proportion By Country (Value), 2016, By Country

Table 26: Global Dermatology Drugs Market Revenue Versus Generic & Branded Sales Proportion By Country (Value), 2016, By Country

Table 27: Prevalent Cases Of Dermatitis, 2014, By Country

Table 28: Asia-Pacific Dermatology Drugs Historic Market, 2012 - 2016

Table 29: Asia-Pacific Dermatology Drugs Forecast Market, 2016 - 2020

Table 30: Asia-Pacific Dermatology Drugs Market, 2016, By Segment

Table 31: China Dermatology Drugs Historic Market, 2012 - 2016

Table 32: China Dermatology Drugs Forecast Market, 2016 - 2020

Table 33: China Dermatology Drugs Market, 2016, By Segment

Table 34: China Dermatology Drugs Percentage Of GDP, 2012 - 2020

Table 35: China Per Capita Average Dermatology Drugs Expenditure, 2012 - 2020

Table 36: India Dermatology Drugs Historic Market, 2012 - 2016

Table 37: India Dermatology Drugs Forecast Market, 2016 - 2020

Table 38: India Dermatology Drugs Market, 2016, By Segment

Table 39: India Dermatology Drugs Percentage Of GDP, 2012 - 2020

Table 40: India Per Capita Average Dermatology Drugs Expenditure, 2012 - 2020

Table 41: Japan Dermatology Drugs Historic Market, 2012 - 2016

Table 42: Japan Dermatology Drugs Forecast Market, 2016 - 2020

Table 43: Japan Dermatology Drugs Market, 2016, By Segment

Table 44: Japan Dermatology Drugs Percentage Of GDP, 2012 - 2020

Table 45: Japan Per Capita Average Dermatology Drugs Expenditure, 2012 - 2020

Table 46: Australia Dermatology Drugs Historic Market, 2012 - 2016

Table 47: Australia Dermatology Drugs Forecast Market, 2016 - 2020

Table 48: Australia Dermatology Drugs Market, 2016, By Segment

Table 49: Australia Dermatology Drugs Percentage Of GDP, 2012 - 2020

Table 50: Australia Per Capita Average Dermatology Drugs Expenditure, 2012 - 2020

Table 51: Western Europe Dermatology Drugs Historic Market, 2012 - 2016

Table 52: Western Europe Dermatology Drugs Forecast Market, 2016 - 2020

Table 53: Western Europe Dermatology Drugs Market, 2016, By Segment

Table 54: UK Dermatology Drugs Historic Market, 2012 - 2016

Table 55: UK Dermatology Drugs Forecast Market, 2016 - 2020

Table 56: UK Dermatology Drugs Market, 2016, By Segment

Table 57: UK Dermatology Drugs Percentage Of GDP, 2012 - 2020

Table 58: UK Per Capita Average Dermatology Drugs Expenditure, 2012 - 2020

Table 59: Germany Dermatology Drugs Historic Market, 2012 - 2016

Table 60: Germany Dermatology Drugs Forecast Market, 2016 - 2020

Table 61: Germany Dermatology Drugs Market, 2016, By Segment

Table 62: Germany Dermatology Drugs Percentage Of GDP, 2012 - 2020

Table 63: Germany Per Capita Average Dermatology Drugs Expenditure, 2012 - 2020

Table 64: France Dermatology Drugs Historic Market, 2012 - 2016

Table 65: France Dermatology Drugs Forecast Market, 2016 - 2020

Table 66: France Dermatology Drugs Market, 2016, By Segment

Table 67: France Dermatology Drugs Percentage Of GDP, 2012 - 2020

Table 68: France Per Capita Average Dermatology Drugs Expenditure, 2012 - 2020

Table 69: Italy Dermatology Drugs Historic Market, 2012 - 2016

Table 70: Italy Dermatology Drugs Forecast Market, 2016 - 2020

Table 71: Italy Dermatology Drugs Market, 2016, By Segment

Table 72: Italy Dermatology Drugs Percentage Of GDP, 2012 - 2020

Table 73: Italy Per Capita Average Dermatology Drugs Expenditure, 2012 - 2020

Table 74: Spain Dermatology Drugs Historic Market, 2012 - 2016

Table 75: Spain Dermatology Drugs Forecast Market, 2016 - 2020

Table 76: Spain Dermatology Drugs Market, 2016, By Segment

Table 77: Spain Dermatology Drugs Percentage Of GDP, 2012 - 2020

Table 78: Spain Per Capita Average Dermatology Drugs Expenditure, 2012 - 2020

Table 79: Eastern Europe Dermatology Drugs Historic Market, 2012 - 2016

Table 80: Eastern Europe Dermatology Drugs Forecast Market, 2016 - 2020

Table 81: Eastern Europe Dermatology Drugs Market, 2016, By Segment

Table 82: Russia Dermatology Drugs Historic Market, 2012 - 2016

Table 83: Russia Dermatology Drugs Forecast Market, 2016 - 2020

Table 84: Russia Dermatology Drugs Market, 2016, By Segment

Table 85: Russia Dermatology Drugs Percentage Of GDP, 2012 - 2020

Table 86: Russia Per Capita Average Dermatology Drugs Expenditure, 2012 - 2020

Table 87: North America Dermatology Drugs Historic Market, 2012 - 2016

Table 88: North America Dermatology Drugs Forecast Market, 2016 - 2020

Table 89: North America Dermatology Drugs Market, 2016, By Segment

Table 90: USA Dermatology Drugs Historic Market, 2012 - 2016

Table 91: USA Dermatology Drugs Forecast Market, 2016 - 2020

Table 92: USA Dermatology Drugs Market, 2016, By Segment

Table 93: USA Dermatology Drugs Percentage Of GDP, 2012 - 2020

Table 94: USA Per Capita Average Dermatology Drugs Expenditure, 2012 - 2020

Table 95: South America Dermatology Drugs Historic Market, 2012 - 2016

Table 96: South America Dermatology Drugs Forecast Market, 2016 - 2020

Table 97: South America Dermatology Drugs Market, 2016, By Segment

Table 98: Brazil Dermatology Drugs Historic Market, 2012 - 2016

Table 99: Brazil Dermatology Drugs Forecast Market, 2016 - 2020

Table 100: Brazil Dermatology Drugs Market, 2016, By Segment

Table 101: Brazil Dermatology Drugs Percentage Of GDP, 2012 - 2020

Table 102: Brazil Per Capita Average Dermatology Drugs Expenditure, 2012 - 2020

Table 103: Middle East Dermatology Drugs Historic Market, 2012 - 2016

Table 104: Middle East Dermatology Drugs Forecast Market, 2016 - 2020

Table 105: Middle East Dermatology Drugs Market, 2016, By Segment

Table 106: Africa Dermatology Drugs Historic Market, 2012 - 2016

Table 107: Africa Dermatology Drugs Forecast Market, 2016 - 2020

Table 108: Africa Dermatology Drugs Market, 2016, By Segment

Table 109: Galderma (Nestle Skin Health) Financial Performance

Table 110: Johnson & Johnson Financial Performance

Table 111: Abbvie Financial Performance

Table 112: Glaxosmithkline Financial Performance

Table 113: Pfizer Financial Performance

Table 114: Pharmaceutical Drugs Market Historic Growth

Table 115: Pharmaceutical Drugs Market Forecast Growth

Table 116: Global Pharmaceutical Drugs Market, 2016, By Region

Table 117: Global Pharmaceutical Drugs Market, 2012 - 2020, Historic And Forecast, By Region

Table 118: Pharmaceutical Drugs Market, 2016, By Country

Table 119: Pharmaceutical Drugs Market, 2012 - 2020, Historic And Forecast, By Country

Table 120: Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Segment

Table 121: Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Country And Segment

Table 122: Pharmaceutical Drugs Market Size, Percentage Of GDP, Global

Table 123: Per Capita Average Pharmaceutical Drugs Expenditure, Global

Table 124: Pharmaceutical Drugs Market Comparison With Macro Economic Factors Across Countries

Table 125: Pharmaceutical Drugs Market Size, Percentage Of GDP, By Country

Table 126: Per Capita Average Pharmaceutical Drugs Expenditure, By Country

Table 127: Pharmaceuticals Industry Financial Margins

List Of Figures, Charts and Diagrams
in Dermatology Drugs Market Global Report 2017 Including: Antibacterial, Anti-Fungal, Anti-Viral Covering: Galderma (Nestle Skin Health), Johnson & Johnson, AbbVie, GlaxosmithKline, and Pfizer [Report Updated: 17-07-2017]

Figure 1: Global Dermatology Drugs Historic Market Growth

Figure 2: Global Dermatology Drugs Forecast Market Growth

Figure 3: Dermatology Drugs Market Segmentation

Figure 4: Global Dermatology Drugs Market, 2016, By Segment

Figure 5: Global Dermatology Drugs Market, 2012 - 2020, Historic And Forecast, By Segment

Figure 6: Global Dermatology Drugs Market, 2016, By Region

Figure 7: Global Dermatology Drugs Market, 2012 - 2020, Historic And Forecast, By Region

Figure 8: Dermatology Drugs Market, 2016, By Country

Figure 9: Dermatology Drugs Market, 2012 - 2020, Historic And Forecast, By Country

Figure 10: Global Pharmaceutical Market Segments, 2016, By Region

Figure 11: Global Pharmaceutical Drugs Market Segments, 2016, By Region

Figure 12: Global Pharmaceutical Market Segments, 2016, By Country

Figure 13: Global Pharmaceutical Drugs Market Segments, 2016, By Country

Figure 14: Dermatology Drugs Market Size, Percentage Of GDP, Global

Figure 15: Per Capita Average Dermatology Drugs Expenditure, Global

Figure 16: Dermatology Drugs Market Comparison With Macro Economic Factors Across Countries

Figure 17: Dermatology Drugs Market Size, Percentage Of GDP, By Country

Figure 18: Per Capita Average Dermatology Drugs Expenditure, By Country

Figure 19: Global Number Of Pharmacists, 2016, By Country

Figure 20: Global Dermatology Drugs Market Revenue Versus Number Of Pharmacists, 2016, By Country

Figure 21: Global Number Of Pharma Enterprises, 2016, By Country

Figure 22: Global Dermatology Drugs Market Revenue Versus Number Of Pharma Enterprises, 2016, By Country

Figure 23: Global Average Spending On R&D/Product Development, 2016, By Country

Figure 24: Global Dermatology Drugs Market Revenue Versus Average Spending On R&D/Product Development, 2016, By Country

Figure 25: Global Generic & Branded Sales Proportion By Country (Value), 2016, By Country

Figure 26: Global Dermatology Drugs Market Revenue Versus Generic & Branded Sales Proportion By Country (Value), 2016, By Country

Figure 27: Prevalent Cases Of Dermatitis, 2014, By Country

Figure 28: Asia-Pacific Dermatology Drugs Historic Market, 2012 - 2016

Figure 29: Asia-Pacific Dermatology Drugs Forecast Market, 2016 - 2020

Figure 30: Asia-Pacific Dermatology Drugs Market, 2016, By Segment

Figure 31: China Dermatology Drugs Historic Market, 2012 - 2016

Figure 32: China Dermatology Drugs Forecast Market, 2016 - 2020

Figure 33: China Dermatology Drugs Market, 2016, By Segment

Figure 34: China Dermatology Drugs Percentage Of GDP, 2012 - 2020

Figure 35: China Per Capita Average Dermatology Drugs Expenditure, 2012 - 2020

Figure 36: India Dermatology Drugs Historic Market, 2012 - 2016

Figure 37: India Dermatology Drugs Forecast Market, 2016 - 2020

Figure 38: India Dermatology Drugs Market, 2016, By Segment

Figure 39: India Dermatology Drugs Percentage Of GDP, 2012 - 2020

Figure 40: India Per Capita Average Dermatology Drugs Expenditure, 2012 - 2020

Figure 41: Japan Dermatology Drugs Historic Market, 2012 - 2016

Figure 42: Japan Dermatology Drugs Forecast Market, 2016 - 2020

Figure 43: Japan Dermatology Drugs Market, 2016, By Segment

Figure 44: Japan Dermatology Drugs Percentage Of GDP, 2012 - 2020

Figure 45: Japan Per Capita Average Dermatology Drugs Expenditure, 2012 - 2020

Figure 46: Australia Dermatology Drugs Historic Market, 2012 - 2016

Figure 47: Australia Dermatology Drugs Forecast Market, 2016 - 2020

Figure 48: Australia Dermatology Drugs Market, 2016, By Segment

Figure 49: Australia Dermatology Drugs Percentage Of GDP, 2012 - 2020

Figure 50: Australia Per Capita Average Dermatology Drugs Expenditure, 2012 - 2020

Figure 51: Western Europe Dermatology Drugs Historic Market, 2012 - 2016

Figure 52: Western Europe Dermatology Drugs Forecast Market, 2016 - 2020

Figure 53: Western Europe Dermatology Drugs Market, 2016, By Segment

Figure 54: UK Dermatology Drugs Historic Market, 2012 - 2016

Figure 55: UK Dermatology Drugs Forecast Market, 2016 - 2020

Figure 56: UK Dermatology Drugs Market, 2016, By Segment

Figure 57: UK Dermatology Drugs Percentage Of GDP, 2012 - 2020

Figure 58: UK Per Capita Average Dermatology Drugs Expenditure, 2012 - 2020

Figure 59: Germany Dermatology Drugs Historic Market, 2012 - 2016

Figure 60: Germany Dermatology Drugs Forecast Market, 2016 - 2020

Figure 61: Germany Dermatology Drugs Market, 2016, By Segment

Figure 62: Germany Dermatology Drugs Percentage Of GDP, 2012 - 2020

Figure 63: Germany Per Capita Average Dermatology Drugs Expenditure, 2012 - 2020

Figure 64: France Dermatology Drugs Historic Market, 2012 - 2016

Figure 65: France Dermatology Drugs Forecast Market, 2016 - 2020

Figure 66: France Dermatology Drugs Market, 2016, By Segment

Figure 67: France Dermatology Drugs Percentage Of GDP, 2012 - 2020

Figure 68: France Per Capita Average Dermatology Drugs Expenditure, 2012 - 2020

Figure 69: Italy Dermatology Drugs Historic Market, 2012 - 2016

Figure 70: Italy Dermatology Drugs Forecast Market, 2016 - 2020

Figure 71: Italy Dermatology Drugs Market, 2016, By Segment

Figure 72: Italy Dermatology Drugs Percentage Of GDP, 2012 - 2020

Figure 73: Italy Per Capita Average Dermatology Drugs Expenditure, 2012 - 2020

Figure 74: Spain Dermatology Drugs Historic Market, 2012 - 2016

Figure 75: Spain Dermatology Drugs Forecast Market, 2016 - 2020

Figure 76: Spain Dermatology Drugs Market, 2016, By Segment

Figure 77: Spain Dermatology Drugs Percentage Of GDP, 2012 - 2020

Figure 78: Spain Per Capita Average Dermatology Drugs Expenditure, 2012 - 2020

Figure 79: Eastern Europe Dermatology Drugs Historic Market, 2012 - 2016

Figure 80: Eastern Europe Dermatology Drugs Forecast Market, 2016 - 2020

Figure 81: Eastern Europe Dermatology Drugs Market, 2016, By Segment

Figure 82: Russia Dermatology Drugs Historic Market, 2012 - 2016

Figure 83: Russia Dermatology Drugs Forecast Market, 2016 - 2020

Figure 84: Russia Dermatology Drugs Market, 2016, By Segment

Figure 85: Russia Dermatology Drugs Percentage Of GDP, 2012 - 2020

Figure 86: Russia Per Capita Average Dermatology Drugs Expenditure, 2012 - 2020

Figure 87: North America Dermatology Drugs Historic Market, 2012 - 2016

Figure 88: North America Dermatology Drugs Forecast Market, 2016 - 2020

Figure 89: North America Dermatology Drugs Market, 2016, By Segment

Figure 90: USA Dermatology Drugs Historic Market, 2012 - 2016

Figure 91: USA Dermatology Drugs Forecast Market, 2016 - 2020

Figure 92: USA Dermatology Drugs Market, 2016, By Segment

Figure 93: USA Dermatology Drugs Percentage Of GDP, 2012 - 2020

Figure 94: USA Per Capita Average Dermatology Drugs Expenditure, 2012 - 2020

Figure 95: South America Dermatology Drugs Historic Market, 2012 - 2016

Figure 96: South America Dermatology Drugs Forecast Market, 2016 - 2020

Figure 97: South America Dermatology Drugs Market, 2016, By Segment

Figure 98: Brazil Dermatology Drugs Historic Market, 2012 - 2016

Figure 99: Brazil Dermatology Drugs Forecast Market, 2016 - 2020

Figure 100: Brazil Dermatology Drugs Market, 2016, By Segment

Figure 101: Brazil Dermatology Drugs Percentage Of GDP, 2012 - 2020

Figure 102: Brazil Per Capita Average Dermatology Drugs Expenditure, 2012 - 2020

Figure 103: Middle East Dermatology Drugs Historic Market, 2012 - 2016

Figure 104: Middle East Dermatology Drugs Forecast Market, 2016 - 2020

Figure 105: Middle East Dermatology Drugs Market, 2016, By Segment

Figure 106: Africa Dermatology Drugs Historic Market, 2012 - 2016

Figure 107: Africa Dermatology Drugs Forecast Market, 2016 - 2020

Figure 108: Africa Dermatology Drugs Market, 2016, By Segment

Figure 109: Galderma (Nestle Skin Health) Financial Performance

Figure 110: Johnson & Johnson Financial Performance

Figure 111: Abbvie Financial Performance

Figure 112: Glaxosmithkline Financial Performance

Figure 113: Pfizer Financial Performance

Figure 114: Pharmaceutical Drugs Market Historic Growth

Figure 115: Pharmaceutical Drugs Market Forecast Growth

Figure 116: Global Pharmaceutical Drugs Market, 2016, By Region

Figure 117: Global Pharmaceutical Drugs Market, 2012 - 2020, Historic And Forecast, By Region

Figure 118: Pharmaceutical Drugs Market, 2016, By Country

Figure 119: Pharmaceutical Drugs Market, 2012 - 2020, Historic And Forecast, By Country

Figure 120: Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Segment

Figure 121: Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Country And Segment

Figure 122: Pharmaceutical Drugs Market Size, Percentage Of GDP, Global

Figure 123: Per Capita Average Pharmaceutical Drugs Expenditure, Global

Figure 124: Pharmaceutical Drugs Market Comparison With Macro Economic Factors Across Countries

Figure 125: Pharmaceutical Drugs Market Size, Percentage Of GDP, By Country

Figure 126: Per Capita Average Pharmaceutical Drugs Expenditure, By Country

Figure 127: Pharmaceuticals Industry Financial Margins

Additional Details

Publisher

The Business Research Company

Publisher Information

The Business Research Company excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.



The Business Research Company’s Consultants have qualifications from top institutes which include MBAs, MSCs, MDs, CFAs and CAs. The Business Research Company’s consultants gain training and qualifications from the Market Research Society and are trained in advanced research practices, techniques, and ethics.

Reference

109253 | 2094

Number of Pages

125

Report Format

PDF

The Business Research Company Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Global Dermatology Partnering 2010-2016: Deal trends, players and financials
The Global Dermatology Partnering 2010-2016: Deal trends, players and financials report provides an ...
01 Nov 2016 by Current Partnering USD $2,995 More Info
Global Dermatology Partnering 2010-2016: Deal trends, players and financials
The Global Dermatology Partnering 2010-2016: Deal trends, players and financials report provides an ...
01 Oct 2016 by Current Partnering USD $2,995 More Info
Global Dermatology Market to 2022 - Innovative Pipeline and Increasing Uptake of Biologics to Diversify Treatment Options and Drive Strong Growth
Global Dermatology Market to 2022 - Innovative Pipeline and Increasing Uptake of Biologics to Divers...
01 May 2016 by GBI Research USD $4,995 More Info
Global Dermatology Market to 2022 - Innovative Pipeline and Increasing Uptake of Biologics to Diversify Treatment Options and Drive Strong Growth
Global Dermatology Market to 2022 - Innovative Pipeline and Increasing Uptake of Biologics to Divers...
01 May 2016 by GBI Research USD $4,995 More Info
Optical Imaging Market by Technique (OCT, NIRS, HSI, PAT) by Product (Imaging System, Camera, Lens, Software) by Therapeutic Area (Ophthalmology, Oncology, Neurology, Dermatology), by Application (Pathological, Intra-operative) - Global Forecast to 2020
The global optical imaging market is expected to grow at a strong CAGR of 12.1% during the forecast ...
01 Feb 2016 by MarketsandMarkets USD $5,650 More Info
Global Dermatology Device Market Outlook 2020
Dermatology devices are speedily gaining popularity not only due to their major role in aesthetic bu...
01 Apr 2015 by RNCOS USD $1,000 More Info
Dermatology Diagnostic Devices Market by Product [Imaging Techniques (OCT, Ultrasound, MRI, CT), Dermatoscopes (Traditional Dermatoscopes, Digital Dermatoscopes), Microscopes], by End-User (Hospitals, Clinics) - Global Forecast to 2019
The global dermatology diagnostic devices market is estimated to grow at a CAGR of 8.2% from 2014 to...
16 Mar 2015 by MicroMarketMonitor USD $4,250 More Info
North American Dermatology Devices Market by Type (Dermatology Treatment Devices, Dermatology Diagnostic Devices) - Forecast to 2019
The North America dermatology devices market is estimated to grow at a CAGR of 10.0% from 2014 to 20...
20 Feb 2015 by MicroMarketMonitor USD $2,650 More Info
North American Dermatology Diagnostic Devices Market by Diagnostic Device (Dermatoscope, Microscope, Imaging Techniques), by Treatment Device (Liposuction, Microdermabrasion, Lasers), by Application - Forecast to 2019
The North American dermatology diagnostic devices market is estimated to grow at a CAGR of 7.9% from...
20 Feb 2015 by MicroMarketMonitor USD $2,650 More Info
Asian Dermatology Devices Market by Type (Dermatology Treatment Devices, Dermatology Diagnostic Devices), by End User (Hospitals, Clinics) - Forecast to 2019
The Asian Dermatology Devices market is estimated to grow at a CAGR of 11.3% from 2014 to 2019. Chin...
10 Feb 2015 by MicroMarketMonitor USD $2,650 More Info

This report is published by The Business Research Company

The Business Research Company excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.

The Business Research Company’s Consultants have qualifications from top institutes which include MBAs, MSCs, MDs, CFAs and CAs. The Business Research Company’s consultants gain training and qualifications from the Market Research Society and are trained in advanced research practices, techniques, and ethics.

Download Free Report Summary PDF

Dermatology Drugs Market Global Report 2017  
Including: Antibacterial, Anti-Fungal, Anti-Viral
Covering: Galderma (Nestle Skin Health), Johnson & Johnson, AbbVie, GlaxosmithKline, and Pfizer [Report Updated: 17-07-2017] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • 360i Research
  • 99Strategy
  • Allied Market Research
  • Asia Market Information & Development Co.
  • Azoth Analytics
  • BioInformant
  • Black Swan Analysis
  • Canadean
  • CBR Pharma Insights
  • CRI
  • Current Analysis
  • Current Partnering
  • Daedal Research
  • Data bridge
  • Delve Insight
  • DPI Research
  • FirstWord Pharma
  • Future Market Insights
  • GBI Research
  • Global Data
  • Global Markets Direct
  • Global Research and Data Services GRDS
  • GMR Data
  • HeyReport
  • HongChun
  • HTStec
  • ICD Research
  • iGATE Research
  • IMARC
  • Industry ARC
  • Inkwood Research
  • IQ4I
  • Jain PharmaBiotech
  • Kelly Scientific
  • La Merie
  • Lifescience Intellipedia
  • LP Information
  • Market Data Forecast
  • Market Research Future
  • Marketline
  • MarketsandMarkets
  • McDerson
  • MedMarket Diligence
  • Meticulous Research
  • MicroMarketMonitor
  • MIReports
  • Mordor Intelligence LLC
  • MP Advisors
  • Occams Business Research
  • Prof Research
  • Progressive Markets
  • ProGrow Pharma Partners
  • Renub
  • Research Impact
  • RNCOS
  • Rockville Research
  • S&P Consulting
  • StratisticsMRC
  • The Business Research Company
  • Triton Market Research
  • Venture Planning Group (VPG)